BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2584020)

  • 1. Dose-response analyses for the Japanese A-bomb survivors.
    Muirhead CR; Butland BK
    Health Phys; 1989 Dec; 57(6):1035-6. PubMed ID: 2584020
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
    Little MP
    Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supra-linear dose-response in the A-bomb study.
    Gofman JW
    Health Phys; 1989 Dec; 57(6):1037-8. PubMed ID: 2584021
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP
    Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
    Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. on: 'No evidence for increased tumor rates below 200 mSv in the atomic bomb survivors' data'.
    Pierce DA; Preston DL
    Radiat Environ Biophys; 1997 Sep; 36(3):209-10; discussion 211-2. PubMed ID: 9402639
    [No Abstract]   [Full Text] [Related]  

  • 8. Late physical disturbances caused by atomic bomb explosions in Japan.
    Kusano N; Shiga H
    Scand J Soc Med Suppl; 1982; 31():60-3. PubMed ID: 6764030
    [No Abstract]   [Full Text] [Related]  

  • 9. Profiles of non-cancer diseases in atomic bomb survivors.
    Kodama K; Fujiwara S; Yamada M; Kasagi F; Shimizu Y; Shigematsu I
    World Health Stat Q; 1996; 49(1):7-16. PubMed ID: 8896251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis.
    Little MP; Weiss HA; Boice JD; Darby SC; Day NE; Muirhead CR
    Radiat Res; 1999 Sep; 152(3):280-92. PubMed ID: 10453089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation-related risk.
    Land CE; Saku T; Hayashi Y; Takahara O; Matsuura H; Tokuoka S; Tokunaga M; Mabuchi K
    Radiat Res; 1996 Jul; 146(1):28-36. PubMed ID: 8677295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.
    Little MP
    Int J Radiat Biol; 2002 Nov; 78(11):1001-10. PubMed ID: 12456287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding estimation of time and age effect-modification of radiation-induced cancer risks among atomic-bomb survivors.
    Lagarde F
    Health Phys; 2006 Dec; 91(6):608-18. PubMed ID: 17099404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comments on the article "Studies of the mortality of atomic bomb survivors. Report 12, part I. Cancer: 1950-1990" by D. A. Pierce, Y. Shimizu. D. L. Preston, M. Vaeth and K. Mabuchi (Radiat. Res. 146, 1-27, 1996).
    Little MP
    Radiat Res; 1997 Oct; 148(4):399-401. PubMed ID: 9339957
    [No Abstract]   [Full Text] [Related]  

  • 15. Statistical significance of supra-linearity of dose-response in the A-bomb study.
    Piepho HP
    Health Phys; 1992 Aug; 63(2):236. PubMed ID: 1399628
    [No Abstract]   [Full Text] [Related]  

  • 16. More about cancer incidence in atomic bomb survivors: solid tumors, 1958-1987.
    Ron E; Preston DL; Mabuchi K
    Radiat Res; 1995 Jan; 141(1):126-7. PubMed ID: 7997509
    [No Abstract]   [Full Text] [Related]  

  • 17. A dose-dependent decrease in the fraction of cases harboring M6P/IGF2R mutations in hepatocellular carcinomas from the atomic bomb survivors.
    Iwamoto KS; Yano S; Barber CL; MacPhee DG; Tokuoka S
    Radiat Res; 2006 Dec; 166(6):870-6. PubMed ID: 17149973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-time patterns for cancer and noncancer excess risks in the atomic bomb survivors.
    Preston DL; Pierce DA; Shimizu Y
    Radiat Res; 2000 Dec; 154(6):733-4;discussion 734-5. PubMed ID: 11187021
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiation safety in children: what we should know.
    Tomà P
    Radiol Med; 2003; 105(1-2):83-91. PubMed ID: 12700550
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of relative biological effectiveness dependence on linear energy transfer for low-LET radiations.
    Hunter N; Muirhead CR
    J Radiol Prot; 2009 Mar; 29(1):5-21. PubMed ID: 19225189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.